Free Trial

Leibman Financial Services Inc. Boosts Stake in Albemarle Corporation $ALB

Albemarle logo with Basic Materials background

Key Points

  • Leibman Financial Services Inc. increased its stake in Albemarle Corporation by 14.6% during the 2nd quarter, now owning 48,871 shares valued at approximately $3.06 million, making it the company's 22nd biggest position.
  • Multiple brokerages have recently adjusted their price targets for Albemarle, with Deutsche Bank setting a target at $74.00 and UBS raising its target from $62.00 to $89.00.
  • Albemarle reported quarterly earnings of $0.11 per share, surpassing consensus estimates, although its revenue was down 7.0% year-over-year, totaling $1.33 billion.
  • Interested in Albemarle? Here are five stocks we like better.

Leibman Financial Services Inc. increased its holdings in Albemarle Corporation (NYSE:ALB - Free Report) by 14.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 48,871 shares of the specialty chemicals company's stock after acquiring an additional 6,237 shares during the quarter. Albemarle comprises approximately 2.4% of Leibman Financial Services Inc.'s portfolio, making the stock its 22nd biggest position. Leibman Financial Services Inc.'s holdings in Albemarle were worth $3,063,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Nuveen LLC purchased a new position in shares of Albemarle in the 1st quarter worth about $26,836,000. Dimensional Fund Advisors LP increased its holdings in Albemarle by 28.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,538,706 shares of the specialty chemicals company's stock worth $110,814,000 after buying an additional 343,210 shares in the last quarter. Hsbc Holdings PLC increased its holdings in Albemarle by 140.5% in the 1st quarter. Hsbc Holdings PLC now owns 458,214 shares of the specialty chemicals company's stock worth $32,996,000 after buying an additional 267,659 shares in the last quarter. Jump Financial LLC grew its stake in shares of Albemarle by 106.4% during the 1st quarter. Jump Financial LLC now owns 415,111 shares of the specialty chemicals company's stock valued at $29,896,000 after purchasing an additional 214,012 shares during the period. Finally, Manning & Napier Advisors LLC grew its stake in shares of Albemarle by 17.4% during the 1st quarter. Manning & Napier Advisors LLC now owns 1,167,520 shares of the specialty chemicals company's stock valued at $84,085,000 after purchasing an additional 173,441 shares during the period. Institutional investors own 92.87% of the company's stock.

Albemarle Stock Up 1.1%

Albemarle stock traded up $0.91 during midday trading on Friday, reaching $81.84. The company's stock had a trading volume of 3,672,039 shares, compared to its average volume of 3,641,829. Albemarle Corporation has a 52-week low of $49.43 and a 52-week high of $113.91. The stock has a market capitalization of $9.63 billion, a P/E ratio of -8.78 and a beta of 1.65. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.31 and a quick ratio of 1.47. The stock's 50-day simple moving average is $77.78 and its 200-day simple moving average is $68.18.

Albemarle (NYSE:ALB - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.83) by $0.94. The firm had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.23 billion. Albemarle had a negative return on equity of 1.87% and a negative net margin of 18.61%.The company's revenue for the quarter was down 7.0% compared to the same quarter last year. During the same period last year, the business posted $0.04 earnings per share. Albemarle has set its FY 2025 guidance at EPS. On average, sell-side analysts expect that Albemarle Corporation will post -0.04 EPS for the current year.

Albemarle Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 1st. Stockholders of record on Friday, September 12th will be paid a $0.405 dividend. The ex-dividend date of this dividend is Friday, September 12th. This represents a $1.62 dividend on an annualized basis and a dividend yield of 2.0%. Albemarle's payout ratio is currently -17.38%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the company. Wells Fargo & Company lowered their price objective on Albemarle from $75.00 to $70.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. JPMorgan Chase & Co. boosted their price target on Albemarle from $60.00 to $80.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Mizuho set a $76.00 price objective on Albemarle in a report on Tuesday, July 15th. KeyCorp reaffirmed a "sector weight" rating on shares of Albemarle in a report on Wednesday, July 30th. Finally, UBS Group upgraded Albemarle from a "sell" rating to a "neutral" rating and increased their price target for the company from $62.00 to $89.00 in a report on Tuesday, August 26th. Three equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and four have issued a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Reduce" and a consensus price target of $86.47.

View Our Latest Research Report on Albemarle

About Albemarle

(Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Read More

Institutional Ownership by Quarter for Albemarle (NYSE:ALB)

Should You Invest $1,000 in Albemarle Right Now?

Before you consider Albemarle, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Albemarle wasn't on the list.

While Albemarle currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Exceptional Growth Stocks to Hold for the Long Haul
5 Stocks Congress Is Buying for the AI Boom
3 Growth Stocks Under $20 with Serious Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines